Lumexa Imaging Holdings, Inc. Common Stock (LMRI) - Total Liabilities
Based on the latest financial reports, Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has total liabilities worth $1.18 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore LMRI cash generation efficiency to assess how effectively this company generates cash.
Lumexa Imaging Holdings, Inc. Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how Lumexa Imaging Holdings, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See LMRI book value for net asset value and shareholders' equity analysis.
Lumexa Imaging Holdings, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Lumexa Imaging Holdings, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Global Mixed-Mode Technology Inc
TW:8081
|
Taiwan | NT$2.13 Billion |
|
GuangDong Rifeng Electric Cable Co Ltd
SHE:002953
|
China | CN¥1.80 Billion |
|
Shenzhen Prince New Materials Co Ltd
SHE:002735
|
China | CN¥1.40 Billion |
|
Oil-Dri Corporation Of America
NYSE:ODC
|
USA | $115.68 Million |
|
Delta Israel Brands Ltd
TA:DLTI
|
Israel | ILA896.54 Million |
|
Shanghai Shenda Co Ltd
SHG:600626
|
China | CN¥6.51 Billion |
|
Beijing Global Safety Technology Co Ltd
SHE:300523
|
China | CN¥2.71 Billion |
|
Nanjing Canatal Data Centre Environmental Tech Co Ltd Class A
SHG:603912
|
China | CN¥2.11 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down Lumexa Imaging Holdings, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Lumexa Imaging Holdings, Inc. Common Sto.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lumexa Imaging Holdings, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lumexa Imaging Holdings, Inc. Common Stock (2023–2025)
The table below shows the annual total liabilities of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.18 Billion | -21.90% |
| 2024-12-31 | $1.51 Billion | +2.43% |
| 2023-12-31 | $1.47 Billion | -- |
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was foun… Read more